Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Frataxin deficiency promotes endothelial senescence in pulmonary hypertension
Miranda K. Culley, … , Thomas Bertero, Stephen Y. Chan
Miranda K. Culley, … , Thomas Bertero, Stephen Y. Chan
Published April 27, 2021
Citation Information: J Clin Invest. 2021;131(11):e136459. https://doi.org/10.1172/JCI136459.
View: Text | PDF
Research Article Pulmonology Vascular biology Article has an altmetric score of 24

Frataxin deficiency promotes endothelial senescence in pulmonary hypertension

  • Text
  • PDF
Abstract

The dynamic regulation of endothelial pathophenotypes in pulmonary hypertension (PH) remains undefined. Cellular senescence is linked to PH with intracardiac shunts; however, its regulation across PH subtypes is unknown. Since endothelial deficiency of iron-sulfur (Fe-S) clusters is pathogenic in PH, we hypothesized that a Fe-S biogenesis protein, frataxin (FXN), controls endothelial senescence. An endothelial subpopulation in rodent and patient lungs across PH subtypes exhibited reduced FXN and elevated senescence. In vitro, hypoxic and inflammatory FXN deficiency abrogated activity of endothelial Fe-S–containing polymerases, promoting replication stress, DNA damage response, and senescence. This was also observed in stem cell–derived endothelial cells from Friedreich’s ataxia (FRDA), a genetic disease of FXN deficiency, ataxia, and cardiomyopathy, often with PH. In vivo, FXN deficiency–dependent senescence drove vessel inflammation, remodeling, and PH, whereas pharmacologic removal of senescent cells in Fxn-deficient rodents ameliorated PH. These data offer a model of endothelial biology in PH, where FXN deficiency generates a senescent endothelial subpopulation, promoting vascular inflammatory and proliferative signals in other cells to drive disease. These findings also establish an endothelial etiology for PH in FRDA and left heart disease and support therapeutic development of senolytic drugs, reversing effects of Fe-S deficiency across PH subtypes.

Authors

Miranda K. Culley, Jingsi Zhao, Yi Yin Tai, Ying Tang, Dror Perk, Vinny Negi, Qiujun Yu, Chen-Shan C. Woodcock, Adam Handen, Gil Speyer, Seungchan Kim, Yen-Chun Lai, Taijyu Satoh, Annie M.M. Watson, Yassmin Al Aaraj, John Sembrat, Mauricio Rojas, Dmitry Goncharov, Elena A. Goncharova, Omar F. Khan, Daniel G. Anderson, James E. Dahlman, Aditi U. Gurkar, Robert Lafyatis, Ahmed U. Fayyaz, Margaret M. Redfield, Mark T. Gladwin, Marlene Rabinovitch, Mingxia Gu, Thomas Bertero, Stephen Y. Chan

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 1 10 10 11 2 34
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (34)

Title and authors Publication Year
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
Harvey LD, Alotaibi M, Tai YY, Tang Y, Kim HJ, Kelly NJ, Sun W, Woodcock CS, Arshad S, Culley MK, El Khoury W, Xie R, Al Aaraj Y, Zhao J, Hafeez N, Rao RJ, Jiang S, Negi V, Kirillova A, Perk D, Watson AM, St. Croix CM, Stolz DB, Lee JY, Cheng MH, Zhang M, Detmer S, Guzman E, Manan RS, Saggar R, Haley KJ, Waxman AB, Okawa S, Schwantes-An TH, Pauciulo MW, Wang B, Webb A, Chauvet C, Anderson DG, Nichols WC, Desai AA, Lafyatis R, Nouraie SM, Wu H, McDonald JG, Cheng S, Bahar I, Bertero T, Benza RL, Jain M, Chan SY
Science (New York, N.Y.) 2025
RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension
Bryce Piper, Srimathi Bogamuwa, Tanvir Hossain, Daniela Farkas, Lorena Rosas, Adam Green, Geoffrey Newcomb, Nuo Sun, Jeffrey Horowitz, Aneel Bhagwani, Hu Yang, Tatiana Kudryashova, Mauricio Rojas, Ana Mora, Pearlly Yan, Rama Mallampalli, Elena Goncharova, David Eckmann, Laszlo Farkas
Journal of Clinical Investigation 2024
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension
Tai YY, Yu Q, Tang Y, Sun W, Kelly NJ, Okawa S, Zhao J, Schwantes-An TH, Lacoux C, Torrino S, Aaraj YA, Khoury WE, Negi V, Liu M, Corey CG, Belmonte F, Vargas SO, Schwartz B, Bhat B, Chau BN, Karnes JH, Satoh T, Barndt RJ, Wu H, Parikh VN, Wang J, Zhang Y, McNamara D, Li G, Speyer G, Wang B, Shiva S, Kaufman B, Kim S, Gomez D, Mari B, Cho MH, Boueiz A, Pauciulo MW, Southgate L, Trembath RC, Sitbon O, Humbert M, Graf S, Morrell NW, Rhodes CJ, Wilkins MR, Nouraie M, Nichols WC, Desai AA, Bertero T, Chan SY
Science Translational Medicine 2024
Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through Krüpple-like factor 4 deacetylation
Zhang J, Xu C, Tang X, Sun S, Liu S, Yang L, Chen Y, Yang Q, Wei TY, Wu X, Wang J, Wang C, Yan X, Yang L, Niu Y, Gou D, Shyy JY, Liu B
Cardiovascular Research 2024
Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension.
Rao RJ, Chan SY
Circulation 2024
miR-21-Mediated Endothelial Senescence and Dysfunction Are Involved in Cigarette Smoke-Induced Pulmonary Hypertension through Activation of PI3K/AKT/mTOR Signaling
He B, Shao B, Cheng C, Ye Z, Yang Y, Fan B, Xia H, Wu H, Liu Q, Zhang J
Toxics 2024
Cell Death in Pulmonary Arterial Hypertension
Li X, Tan J, Wan J, Cheng B, Wang YH, Dai A
International journal of medical sciences 2024
Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain
Safaie Qamsari E, Stewart DJ
Frontiers in Immunology 2024
Identification and experimental verification of senescence-related gene signatures and molecular subtypes in idiopathic pulmonary arterial hypertension
Meng ZY, Lu CH, Li J, Liao J, Wen H, Li Y, Huang F, Zeng ZY
Scientific Reports 2024
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target
Légaré C, Berglund JA, Duchesne E, Dumont NA
Bioessays 2024
Frataxin Loss Promotes Angiotensin II–Induced Endothelial‐to‐Mesenchymal Transition
Guo Y, Cheng X, Huang C, Gao J, Shen W
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2024
PGC-1α-mediated angiogenesis prevents pulmonary hypertension in mice
Takayuki Fujiwara, Norifumi Takeda, Hironori Hara, Satoshi Ishii, Genri Numata, Hiroyuki Tokiwa, Manami Katoh, Sonoko Maemura, Takaaki Suzuki, Hiroshi Takiguchi, Tomonobu Yanase, Yoshiaki Kubota, Seitaro Nomura, Masaru Hatano, Kazutaka Ueda, Mutsuo Harada, Haruhiro Toko, Eiki Takimoto, Hiroshi Akazawa, Hiroyuki Morita, Satoshi Nishimura, Issei Komuro
JCI Insight 2023
Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4‐Human Leukocyte Antigen‐DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension
Hafeez N, Kirillova A, Yue Y, Rao RJ, Kelly NJ, El Khoury W, Al Aaraj Y, Tai Y, Handen A, Tang Y, Jiang D, Wu T, Zhang Y, McNamara D, Kudryashova TV, Goncharova EA, Goncharov D, Bertero T, Nouraie M, Li G, Sun W, Chan SY
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2023
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
Suda M, Paul KH, Minamino T, Miller JD, Lerman A, Ellison-Hughes GM, Tchkonia T, Kirkland JL
Cells 2023
Endothelial cell senescence exacerbates pulmonary hypertension by inducing juxtacrine Notch signaling in smooth muscle cells
Ramadhiani R, Ikeda K, Miyagawa K, Ryanto GR, Tamada N, Suzuki Y, Kirita Y, Matoba S, Hirata KI, Emoto N
iScience 2023
Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?
Riou M, Enache I, Sauer F, Charles AL, Geny B
International journal of molecular sciences 2023
TGFβ signaling pathways in human health and disease
Chen PY, Qin L, Simons M
Frontiers in Molecular Biosciences 2023
Vascular Inflammatory Diseases and Endothelial Phenotypes
Immanuel J, Yun S
Cells 2023
SIRT3 Regulates Clearance of Apoptotic Cardiomyocytes by Deacetylating Frataxin
Gao J, Huang C, Kong L, Zhou W, Sun M, Wei T, Shen W
Circulation research 2023
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function
Culley MK, Rao RJ, Mehta M, Zhao J, Khoury WE, Harvey LD, Perk D, Tai YY, Tang Y, Shiva S, Rabinovitch M, Gu M, Bertero T, Chan SY
Vascular Pharmacology 2023
The mechanism of ferroptosis and its related diseases
Feng S, Tang D, Wang Y, Li X, Bao H, Tang C, Dong X, Li X, Yang Q, Yan Y, Yin Z, Shang T, Zheng K, Huang X, Wei Z, Wang K, Qi S
2023
Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation
Ratoe Suraya, Tatsuya Nagano, Gusty R.T. Ryanto, Wiwin I. Effendi, Daisuke Hazama, Naoko Katsurada, Masatsugu Yamamoto, Motoko Tachihara, Noriaki Emoto, Yoshihiro Nishimura, Kazuyuki Kobayashi
Respiratory Research 2022
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure
O Boucherat, V Agrawal, A Lawrie, S Bonnet
Circulation research 2022
Endothelial Senescence: A New Age in Pulmonary Hypertension
M Culley, S Chan
Circulation research 2022
Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies
H Christou, R Khalil
American journal of physiology. Heart and circulatory physiology 2022
Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension.
Florentin J, Zhao J, Tai YY, Sun W, Ohayon LL, O'Neil SP, Arunkumar A, Zhang X, Zhu J, Al Aaraj Y, Watson A, Sembrat J, Rojas M, Chan SY, Dutta P
Life science alliance 2022
Perspectives on current models of Friedreich’s ataxia
Kelekçi S, Yıldız AB, Sevinç K, Çimen DU, Önder T
Frontiers in Cell and Developmental Biology 2022
Mechanisms and consequences of endothelial cell senescence.
Bloom SI, Islam MT, Lesniewski LA, Donato AJ
Nature reviews. Cardiology 2022
Endothelial senescence mediates hypoxia-induced vascular remodeling by modulating PDGFB expression
Kyi P, Hendee K, Hunyenyiwa T, Matus K, Mammoto T, Mammoto A
Frontiers in Medicine 2022
Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice
Kelly NJ, Chan SY
2022
How a fibroblast ages: a role for bone morphogenetic protein 4 in protecting lung fibroblasts from senescence in pulmonary fibrosis.
Farkas L, Horowitz JC, Mora AL
European Respiratory Journal 2022
Therapeutic opportunities for senolysis in cardiovascular disease
Sweeney M, Cook SA, Gil J
The FEBS journal 2022
Frataxin and endothelial cell senescence in pulmonary hypertension
Allan Lawrie
Journal of Clinical Investigation 2021
Senescence Alterations in Pulmonary Hypertension
I Roger, J Milara, N Belhadj, J Cortijo
Cells 2021

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 37 X users
54 readers on Mendeley
See more details